文献速递心境障碍精神分裂症与精神病性障碍

自杀死亡的全基因组关联研究及临床前因的多基因预测

Genome-Wide Association Study of Suicide Death and Polygenic Prediction of Clinical Antecedents.
PubMed 文献 · Am J Psychiatry · 2020-01-01

该研究对3413例欧洲裔自杀死亡病例和14810例祖先匹配对照进行全基因组关联分析,发现两个全基因组显著位点(涉及6个SNP)和22个基因,自杀死亡的SNP遗传度为0.25(SE=0.04), liability scale为0.16(SE=0.02),多基因评分在独立训练集和测试集中显著预测自杀死亡状态,且行为去抑制和重度抑郁障碍的多基因评分也有预测作用。

要点

  • 自杀死亡存在全基因组显著位点(6个SNP)和22个基因(q<0.05)。
  • 自杀死亡SNP遗传度为0.25(SE=0.04),liability scale为0.16(SE=0.02)。
  • 自杀多基因评分在独立训练和测试集中显著预测自杀死亡状态。

核心结论

  • 自杀死亡具有多基因遗传基础,多基因评分可预测自杀死亡病例对照状态。

研究设计与样本

  • 研究纳入3413例欧洲裔自杀死亡病例和14810例祖先匹配对照,进行全基因组关联分析、基因和基因集富集分析、多基因评分分析及LD Score回归估计遗传度和遗传相关性。

主要发现

  • 全基因组关联分析发现两个全基因组显著位点,涉及6个SNP:rs34399104、rs35518298、rs34053895、rs66828456、rs35502061和rs35256367。
  • 基于基因的分析在13、15、16、17和19号染色体上发现22个基因(q<0.05)。
  • 自杀死亡SNP遗传度为0.25(SE=0.04),转换为liability scale为0.16(SE=0.02)。
  • 自杀多基因评分在训练集和测试集中显著预测自杀死亡状态。
  • 行为去抑制、重度抑郁障碍、抑郁症状、孤独症谱系障碍、精神病性和酒精使用障碍的多基因评分也显著预测自杀死亡。

关键数值与推荐

  • 全基因组显著位点涉及6个SNP:rs34399104、rs35518298、rs34053895、rs66828456、rs35502061和rs35256367。
  • 基于基因的分析发现22个基因(q<0.05)。
  • 自杀死亡SNP遗传度h2SNP=0.25(SE=0.04),liability scale=0.16(SE=0.02)。

临床怎么用

  • 多基因评分可能有助于识别自杀死亡高风险个体,但需在独立人群中进一步验证。
  • 自杀死亡样本中行为去抑制和重度抑郁障碍的多基因评分显著预测自杀死亡,提示临床评估应关注冲动和抑郁症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Death by suicide is a highly preventable yet growing worldwide health crisis. To date, there has been a lack of adequately powered genomic studies of suicide, with no sizable suicide death cohorts available for analysis. To address this limitation, the authors conducted the first comprehensive genomic analysis of suicide death using previously unpublished genotype data from a large population-ascertained cohort. METHODS: The analysis sample comprised 3,413 population-ascertained case subjects of European ancestry and 14,810 ancestrally matched control subjects. Analytical methods included principal component analysis for ancestral matching and adjusting for population stratification, linear mixed model genome-wide association testing (conditional on genetic-relatedness matrix), gene and gene set-enrichment testing, and polygenic score analyses, as well as single-nucleotide polymorphism (SNP) heritability and genetic correlation estimation using linkage disequilibrium score regression. RESULTS: Genome-wide association analysis identified two genome-wide significant loci (involving six SNPs: rs34399104, rs35518298, rs34053895, rs66828456, rs35502061, and rs35256367). Gene-based analyses implicated 22 genes on chromosomes 13, 15, 16, 17, and 19 (q<0.05). Suicide death heritability was estimated at an h2SNP value of 0.25 (SE=0.04) and a value of 0.16 (SE=0.02) when converted to a liability scale. Notably, suicide polygenic scores were significantly predictive across training and test sets. Polygenic scores for several other psychiatric disorders and psychological traits were also predictive, particularly scores for behavioral disinhibition and major depressive disorder. CONCLUSIONS: Multiple genome-wide significant loci and genes were identified and polygenic score prediction of suicide death case-control status was demonstrated, adjusting for ancestry, in independent training and test sets. Additionally, the suicide death sample was found to have increased genetic risk for behavioral disinhibition, major depressive disorder, depressive symptoms, autism spectrum disorder, psychosis, and alcohol use disorder compared with the control sample.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Docherty AR, Shabalin AA, DiBlasi E, et al. Genome-Wide Association Study of Suicide Death and Polygenic Prediction of Clinical Antecedents. Am J Psychiatry. 2020. PMID: 32998551. doi:10.1176/appi.ajp.2020.19101025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。